And it makes a wonderful distraction from the Epstein files. Remember them?
Assuming a wag-the-dog strategy at work(*), the anti-Iranian aggression was likely supposed to be the primary distraction from Epstein. But while it has technically succeeded in that goal, it's almost certainly not in the way that Trump had hoped, since the war has been getting, at best, middling approval numbers from hoi poloi. So Trump would likely want a distraction from the distraction, as it were, and back-and-forth jab fests with the pontiff might've seemed like an attractive option.
(*) Not usually my first assumption, but with Trump I could see it, throwing in the caveat that it's also in the long term interests of the USA, as those interests are defined by certain factions of long-standing influence in American policy.
I assume some of the big pharma firms are gonna do well on this, 'cuz I don't see doctors sourcing the medication from the local hippie botanist down in the valley.
Looking into the American companies involved with ibogaine, they seem to me like mostly start-ups that are publically traded on the stock market but haven't yet garnered their own wikipedia pages. At least one of them has a weird pun as its name.
And if I'm understanding the wikipedia page on the drug's legality in respective nations, some places are currently more liberal than the USA, some places less. Trump being Trump, I'm guessing that somewhere in his mind, he's thinking that pushing the research forward will soon result in America dominating the market for the future pharmaceuticals.
I was many years in fundamental drug development (with a well replected US corporation, as it happens) and I'm not (yet) aware of any proper clinical trials of this compound. Surely the legal registration of Ibogaine will take some time yet?
Comments
Assuming a wag-the-dog strategy at work(*), the anti-Iranian aggression was likely supposed to be the primary distraction from Epstein. But while it has technically succeeded in that goal, it's almost certainly not in the way that Trump had hoped, since the war has been getting, at best, middling approval numbers from hoi poloi. So Trump would likely want a distraction from the distraction, as it were, and back-and-forth jab fests with the pontiff might've seemed like an attractive option.
(*) Not usually my first assumption, but with Trump I could see it, throwing in the caveat that it's also in the long term interests of the USA, as those interests are defined by certain factions of long-standing influence in American policy.
I was many years in fundamental drug development (with a well replected US corporation, as it happens) and I'm not (yet) aware of any proper clinical trials of this compound. Surely the legal registration of Ibogaine will take some time yet?